cidofovir anhydrous has been researched along with Hemangioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liekens, S | 1 |
| Andrei, G; De Clercq, E; Liekens, S; Neyts, J; Vandeputte, M | 1 |
1 review(s) available for cidofovir anhydrous and Hemangioma
| Article | Year |
|---|---|
The role of growth factors, angiogenic enzymes and apoptosis in neovascularization and tumor growth-collected publications.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cidofovir; Cyclohexanes; Cytosine; Disease Models, Animal; Fibroblast Growth Factor 2; Growth Substances; Hemangioma; Humans; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Organophosphonates; Organophosphorus Compounds; Rats; Sesquiterpenes; Thymidine Phosphorylase; Tumor Virus Infections | 2002 |
1 other study(ies) available for cidofovir anhydrous and Hemangioma
| Article | Year |
|---|---|
Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir.
Topics: Animals; Antiviral Agents; Body Weight; Brain Neoplasms; Cidofovir; Cytosine; Hemangioma; Incidence; Organophosphonates; Organophosphorus Compounds; Polyomavirus; Rats; Rats, Wistar; Skin Neoplasms; Survival Analysis | 1998 |